Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ADH5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TNIP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNX9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WDR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BBS12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
XIAP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NPL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ABL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TPR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NSFL1C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM121 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MTMR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PIM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARPC5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NMT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRDM5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CAST - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RUFY3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LAPTM4B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on